Quanterix Corporation
Quanterix Corporation (QTRX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · QTRX · as of Jun 8, 2026
Key Statistics
Explore Quanterix Corporation Data
qtrx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 10 · Buy rate: 50.0%
The QTRX analyst consensus is Buy, based on ratings from 10 Wall Street analysts over the past 3 months. The average 12-month price target is $4.00, representing +27.80% upside from the current price of $3.13.
Competitors & Peers
qtrx competitorsQTRX
CVRX
IMRX
INGN
MASS
NNOXStock Performance
Full HistoryAbout Quanterix Corporation
Quanterix Corporation based in Billerica, Massachusetts, is a life sciences enterprise dedicated to pioneering and commercializing advanced digital immunoassay platforms. These sophisticated systems …
what is quanterix corporation · qtrx stock overview · quanterix corporation company profile · who is quanterix corporation ceo · qtrx NASDAQ · quanterix corporation headquarters · quanterix corporation business segments
About Stock Overview & Key Data
Quanterix Corporation (QTRX) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Dec 7, 2017. As of the latest trading session, QTRX stock price is $3.13, with a market capitalization of $147.4M. The stock has returned -38.14% over the past 12 months and -50.79% year-to-date.
According to 10 Wall Street analysts, the consensus rating for Quanterix Corporation stock is Buy, with an average 12-month price target of $4.00. In fiscal year 2025, Quanterix Corporation reported revenue of $138.7M and net income of -$107.2M. For detailed data — including Quanterix Corporation revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Quanterix Corporation (QTRX) stock price is $3.13. The stock is traded on NASDAQ under the ticker symbol QTRX. The 52-week range is $2.40 – $8.77.